CANNAPHARMARX, INC. Debt Conversion, Converted Instrument, Amount
CANNAPHARMARX, INC. (CPMD) reported Debt Conversion, Converted Instrument, Amount of $134.91 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-03-31
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for the quarter ending 2025-03-31 was $134.91K, a 114.45% increase year-over-year.
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for the quarter ending 2024-09-30 was $0.00.
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for fiscal 2024 was $134.91K, a 39.26% decline from fiscal 2023.
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for fiscal 2023 was $222.10K.
- CANNAPHARMARX, INC. debt conversion, converted instrument, amount for fiscal 2019 was $5.08M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $134.91K 10-Q · filed 2025-08-14 | $134.91K derived: sum of 3 quarters · filed 2026-03-31 | $134.91K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $134.91K 10-Q · filed 2025-05-16 | $134.91K derived: sum of 2 quarters · filed 2026-03-31 | $134.91K derived: sum of 3 quarters · filed 2026-03-31 | $206.91K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $72.00K derived: sum of 3 quarters · filed 2026-03-31 | $134.91K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $72.00K derived: sum of 2 quarters · filed 2025-08-14 | $134.91K 10-Q · filed 2024-11-14 | $219.06K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $134.91K 10-Q · filed 2025-08-14 | $219.06K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | $62.91K 10-Q · filed 2024-06-25 | $147.06K derived: sum of 2 quarters · filed 2025-04-10 | ||
| 2023-12-31 | $84.15K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | $222.10K 10-K · filed 2025-04-10 | ||
| 2023-09-30 | $137.95K 10-Q · filed 2023-11-17 | |||
| 2022-12-31 | $552.52K 10-Q · filed 2023-11-17 | |||
| 2020-09-30 | $306.75K 10-Q · filed 2020-11-12 | |||
| 2020-03-31 | $130.85K 10-Q · filed 2020-11-12 | |||
| 2019-12-31 | $5.08M 10-K · filed 2021-04-14 | |||
| 2019-09-30 | $3.80M 10-Q · filed 2020-11-12 |